## Clinical Case Analysis: Tuberculoid Leprosy Classification ### Patient Presentation Breakdown | Finding | Interpretation | |---------|----------------| | **Asymmetric hypopigmented patches** | Characteristic of tuberculoid leprosy | | **Loss of sensation in lesions** | Early, asymmetric nerve involvement (typical of TT) | | **0–2 bacilli per field (slit-skin smear)** | Paucibacillary status (TT hallmark) | | **Strongly positive lepromin test** | Strong cell-mediated immunity (TT hallmark) | ### Diagnosis: Tuberculoid Leprosy (TT) **Key Point:** This patient has all the classic features of tuberculoid leprosy: 1. Few, well-demarcated lesions 2. Paucibacillary (≤5 bacilli) 3. Positive lepromin test 4. Early, asymmetric nerve involvement ### Treatment Duration: The Critical Distinction **High-Yield:** WHO multidrug therapy (MDT) duration is determined by **bacillary load**, not clinical form: | Classification | Bacilli | MDT Duration | Drugs | |---|---|---|---| | **Paucibacillary (PB)** | ≤5 bacilli | **6 months** | Rifampicin + Dapsone + Clofazimine | | **Multibacillary (MB)** | >5 bacilli | **12 months** | Rifampicin + Dapsone + Clofazimine | **Why Option 4 Is Wrong:** This patient has **paucibacillary leprosy** (0–2 bacilli per field), which requires **6 months of MDT**, not 12 months. The statement "his lepromatous bacillary load requires 12 months" is doubly incorrect: 1. He does NOT have lepromatous leprosy (he has tuberculoid) 2. His paucibacillary status mandates 6-month therapy ### Clinical Pearl: Disability Risk Paradox **Mnemonic: TB = Trouble for Nerves** - Tuberculoid leprosy has **fewer bacilli** but **more nerve damage** (early, asymmetric) - Lepromatous leprosy has **more bacilli** but **less early nerve damage** (late, symmetric) - This is because strong CMI in TT causes granulomatous inflammation around nerves ### Lepromin Test Interpretation **Key Point:** Lepromin (Mitsuda) test: - **Positive** → tuberculoid, borderline-tuberculoid → good prognosis - **Negative** → lepromatous, borderline-lepromatous → poor prognosis - **Indeterminate** → borderline leprosy (unstable) [cite:Park 26e Ch 10; WHO Leprosy Guidelines 2023]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.